Effects of repeated praziquantel treatment on schistosomiasis mekongi morbidity as detected by ultrasonography

Parasitology International

Volumn 55, Issue 4, 2006, Pages 261-265

  Chigusa, Yuichi ^a   Ohmae, Hiroshi ^b   Otake, Hidehiro ^a,c   Keang, Hong ^d   Sinuon, Muth ^d   Saem, Cheam ^d   Socheat, Duong ^d   Matsuda, Hajime ^a  

^a DOKKYO MEDICAL UNIVERSITY   (Japan)

^b NATIONAL INSTITUTE OF INFECTIOUS DISEASES   (Japan)

^c Kure University   (Japan)

^d Ministry of Health Cambodia   (Cambodia)

Author keywords

Cambodia; Periportal fibrosis; Praziquantel; Schistosoma mekongi; Splenomegaly; Ultrasonography

Indexed keywords

PRAZIQUANTEL;

ADOLESCENT; ADULT; AGED; ARTICLE; CAMBODIA; COLLATERAL CIRCULATION; CONTROLLED STUDY; ECHOGRAPHY; FEMALE; HUMAN; ISCHEMIA; MAJOR CLINICAL STUDY; MALE; MICROORGANISM DETECTION; MORBIDITY; OBSERVER BIAS; PORTAL VEIN; PRIORITY JOURNAL; SCHISTOSOMIASIS; SCHOOL CHILD; SPLENIC VEIN; SPLENOMEGALY; TREATMENT DURATION; VEIN DISEASE;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANIMALS; ANTHELMINTICS; CAMBODIA; CHILD; FEMALE; HUMANS; MALE; MIDDLE AGED; MORBIDITY; PORTAL VEIN; PRAZIQUANTEL; SCHISTOSOMA; SCHISTOSOMIASIS; SPLENIC VEIN; SPLENOMEGALY;

SCHISTOSOMA MEKONGI;

EID: 33750991091     PISSN: 13835769     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.parint.2006.06.005     Document Type: Article

References (20)

1. Sornmani S., Kitikoon V., Thirachantra S., and Harinasuta C. Epidemiology of mekong schistosomiasis. In: Bruce J.I., and Sormani S. (Eds). The mekong schistosome (1980), The Edna McConnell Clark Foundation, Michigan 9-18
2. Vic-Dupont B.E., Soubrane J., Halle B., and Richir C. Bilharziose a Schistosoma japonicum a forme hepatosplenique revelee par une grande hematemese. Bull Mem Soc Med Hop Paris 73 (1957) 933-994
3. Audebaud G., Tournier-Lasserve C., Brumpt V., Jolly M., Mazaud R., Imbert X., et al. 1st case of human schistosomiasis observed in Cambodia (Kratie area). Bull Soc Pathol Exot Ses Fil 61 (1968) 778-784
4. Voge M., Bruckner D., and Bruce J.I. Schistosoma mekongi sp. n. from man and animals, compared with four geographic strains Schistosoma japonicum. J Parasitol 64 (1978) 577-584
5. Stich A.H.R., Biays S., Odermatt P., Chan M., Cheam S., Kiev S., et al. Foci of schistosomiasis mekongi, Northern Cambodia: II Distribution of infection and morbidity. Trop Med Int Health 4 (1999) 674-685
6. Biays S., Stich A.H.R., Odermatt P., Long C., Yersin C., Men C., et al. Foyer de bilharziose a Schistosoma mekongi redecouvert au Nord du Cambodge: 1. Perception culturelle de la maladie; description et suivi de 20 cas cliniques graves. Trop Med Int Health 4 (1999) 662-673 (In French with English summary)
7. Ohmae H., Sinuon M., Kirinoki M., Matsumoto J., Chigusa Y., Socheat D., et al. Schistosomiasis mekongi: from discovery to control. Parasitol Int 53 (2004) 135-142
8. Urbani C., Sinoun M., Socheat D., Pholsena K., Strandgaard H., Odermatt P., et al. Epidemiology and control of mekongi schistosomiasis. Acta Trop 82 (2002) 157-168
9. Tang Z.P. An analysis of ultrasonography in 157 patients with schistosomiasis. Chin J Clin Hepatol 2 (1986) 39
10. Cai W.M. Ultrasonographic diagnosis of hepatic lesions in 50 advanced patients with schistosomiasis japonica. Zhejiang Med J 9 (1987) 22
11. Ohmae H., Tanaka M., Hayashi M., Matsuzaki Y., Kurosaki Y., Blas B.L., et al. Ultrasonographic and serologic abnormalities in Schistosoma japonicum infection in Leyte, the Philippines. Am J Trop Med Hyg 46 (1992) 89-98
12. Wiest P.M., Wu G., Zhong S., Yuan J., Peters P.A.S., McGravey S.T., et al. Morbidity due to schistosomiasis japonica in the People's Republic of China: persistence of hepatic fibrosis after reduction of the prevalence of infection with age. Trans R Soc Trop Med Hyg 86 (1992) 47-50
13. Hatz C. In: Baker J.R., Muller R., and Robinson D. (Eds). The use of ultrasounds in schistosomiasis. Advances in parasitology vol. 48 (2001), Academic Press, San Diego 225-284
14. Hatz C., Odermatt P., and Urbani C. Preliminary data on morbidity due to Schistosoma mekongi infections among the population of Sdau village, northern Cambodia (1996), Médecins sans Frontières report, Phnom Penh
15. Li Y.S., Sleigh A.C., Ross A.G., Li Y., Williams G.M., Tanner M., et al. Two-year impact of praziquantel treatment for Schistosoma japonicum infection in China: re-infection, subclinical disease and fibrosis marker measurements. Trans R Soc Trop Med Hyg 94 (2000) 191-197
16. Doehring-Schwerdtfeger E., Abdel-Rahim I.M., Kardorff R., Kaiser C., Franke D., Schlake J., et al. Ultrasonographical investigation of periportal fibrosis in children with Schistosoma mansoni infection: reversibility of morbidity twenty-three months after treatment with praziquantel. Am J Trop Med Hyg 46 (1992) 409-415
17. Mohamed-Ali Q., Doehring-Schwerdtfeger E., Abdel-Rahim I.M., Schlake J., Kardorff R., Franke D., et al. Ultrasonographical investigation of periportal fibrosis in children with Schistosoma mansoni infection: reversibility of morbidity seven months after treatment with praziquantel. Am J Trop Med Hyg 44 (1991) 444-451
18. Booth M., Vennervald B.J., Kenty L., Butterworth A.E., Kariuki H.C., Kadzo H., et al. Micro-geographical variation in exposure to Schistosoma mansoni and malaria, and exacerbation of splenomegaly in Kenyan school-aged children. BMC Infect Dis 4 (2003) (Article No. 13)
19. Booth M., Vennervald B.J., Butterworth A.E., Kariuki H.C., Amaganga C., Kimani G., et al. Exposure to malaria affects the regression of hepatosplenomegaly after treatment for Schistosoma mansoni infection in Kenyan children. BMC Med 2 (2004) (Article No. 36)
20. Boisier P., Ramarokoto C.E., Ravaoalimalala V.E., Rabarijaona L., Serieye J., Roux J., et al. Reversibility of Schistosoma mansoni-associated morbidity after yearly mass praziquantel therapy: ultrasonographic assessment. Trans R Soc Trop Med Hyg 92 (1998) 451-453